Retrospective Natural History Study of Infants and Toddlers With LAMA2-CMD

CompletedOBSERVATIONAL
Enrollment

75

Participants

Timeline

Start Date

April 24, 2020

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Merosin Deficient Congenital Muscular Dystrophy
Trial Locations (1)

90712

Cure CMD, Inc., Lakewood

All Listed Sponsors
collaborator

Cure CMD

OTHER

collaborator

The Bönnemann Laboratory, NINDS, National Institutes of Health

UNKNOWN

collaborator

Oscar H Mayer, MD, Children's Hospital of Philadelphia

UNKNOWN

collaborator

The Beggs Laboratory, Boston Children's Hospital

UNKNOWN

lead

Prothelia, Inc.

INDUSTRY

NCT04299321 - Retrospective Natural History Study of Infants and Toddlers With LAMA2-CMD | Biotech Hunter | Biotech Hunter